Search





Search





Markets
/
Stocks
/
tlsa
/

Tiziana Life Sciences Ltd

TLSA

Add to Watchlist

1.030USD

+0.060+6.19%

Close 07-31 16:00（ET）Quotes delayed by 15 min

131.08MMarket Cap

LossP/E TTM

Tiziana Life Sciences Ltd

1.030

+0.060+6.19%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

TLSA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Tiziana Life Sciences Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

FY2018H1

FY2017H2

FY2017H1

FY2016H2

FY2016H1

FY2015H2

FY2015H1

FY2014H2

FY2014H1

FY2013H2

FY2013H1

FY2012H2

FY2012H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

55.27%-1.93M

103.51%400.00K

44.09%-4.31M

4.37%-11.39M

---7.70M

8.64%-11.91M

-104.40%-13.04M

-173.78%-5.53M

-32.55%-6.38M

-11.75%-2.02M

-70.38%-4.81M

46.95%-1.81M

31.29%-2.82M

24.36%-3.41M

-81.16%-4.11M

-58.46%-4.50M

59.26%-2.27M

-36.13%-2.84M

-243.77%-5.57M

-2333.18%-2.09M

-555.79%-1.62M

145.14%93.46K

-55.16%-247.07K

---207.05K

---159.24K

Net income from continuing operations

-1.63%-8.77M

7.39%-7.98M

20.76%-8.63M

-90.94%-8.62M

---10.88M

74.16%-4.51M

-252.35%-17.46M

-354.99%-23.68M

-3.20%-4.96M

-13.30%-5.20M

9.49%-4.80M

20.47%-4.59M

-8.91%-5.31M

12.85%-5.78M

-61.38%-4.87M

4.36%-6.63M

51.80%-3.02M

-113.71%-6.93M

-138.47%-6.26M

-1111.01%-3.24M

-1392.00%-2.63M

52.65%-267.70K

62.53%-176.04K

---565.42K

---469.82K

Operating gains losses

51.22%62.00K

12.73%62.00K

-18.00%41.00K

1000.00%55.00K

--50.00K

-93.56%5.00K

168.13%77.69K

39.47%346.02K

2140.79%28.98K

3095.28%248.10K

-84.32%1.29K

-1.81%7.76K

31.13%8.25K

-22.57%7.91K

--6.29K

--10.21K

----

Other non-cash items

541.53%3.10M

-85.08%227.00K

117.75%484.00K

141.32%1.52M

---2.73M

-44321.41%-3.68M

102.08%8.32K

7642.56%14.53M

-599.70%-400.61K

502.79%187.65K

141.36%80.17K

66.01%-46.59K

-1640.74%-193.82K

-126.84%-137.06K

-85.85%12.58K

--510.59K

--88.87K

100.00%0.00

-100.00%0.00

-354.95%-298.85K

5639.23%1.60M

-57.70%117.22K

-91.68%27.80K

--277.13K

--334.24K

Change in working capital

-162.01%-2.24M

132.46%1.68M

449.70%3.61M

-185.05%-5.19M

--656.00K

-1443.37%-1.82M

96.00%-117.92K

313.54%2.76M

-649.60%-2.95M

106.75%666.21K

-123.69%-393.10K

-80.93%322.23K

140.68%1.66M

261.64%1.69M

17.01%689.35K

369.03%467.19K

349.48%589.15K

-90.45%99.61K

67.98%-236.15K

353.98%1.04M

-818.52%-737.56K

243.35%229.68K

-748.86%-80.30K

--66.89K

---9.46K

-Change in receivables

-155.93%-547.00K

65.15%-844.00K

261.39%978.00K

-638.22%-2.42M

---606.00K

-59.51%450.00K

146.57%1.11M

1640.09%2.00M

-61607.97%-2.39M

86.17%-129.72K

-99.52%3.88K

-1523.81%-938.22K

6547.07%811.00K

115.32%65.89K

-103.54%-12.58K

-56.82%-430.17K

797.44%355.50K

-211.11%-274.30K

109.77%39.61K

471.08%246.88K

-26158.79%-405.49K

---66.53K

---1.54K

--0.00

-Change in payables and accrued expense

----

-370.64%-988.43K

----

-67.41%365.22K

-146.81%-396.98K

-30.98%1.12M

20.83%848.11K

80.93%1.62M

200.41%701.93K

139.99%897.36K

184.73%233.65K

-53.02%373.91K

16.96%-275.76K

168.68%795.85K

-321.65%-332.07K

342.80%296.21K

-732.54%-78.75K

--66.89K

---9.46K

-Change in other current liabilities

-164.27%-1.69M

191.40%2.53M

108.24%2.63M

-21.85%-2.77M

--1.26M

-84.68%-2.27M

-119.26%-1.23M

305.32%1.75M

---560.61K

208.17%430.71K

----

--139.76K

----

Cash from non-recurring investing activities

Cash from operating activities

55.27%-1.93M

103.51%400.00K

44.09%-4.31M

4.37%-11.39M

---7.70M

8.64%-11.91M

-104.40%-13.04M

-173.78%-5.53M

-32.55%-6.38M

-11.75%-2.02M

-70.38%-4.81M

46.95%-1.81M

31.29%-2.82M

24.36%-3.41M

-81.16%-4.11M

-58.46%-4.50M

59.26%-2.27M

-36.13%-2.84M

-243.77%-5.57M

-2333.18%-2.09M

-555.79%-1.62M

145.14%93.46K

-55.16%-247.07K

---207.05K

---159.24K

Investing cash flow

Net cash from continuing investing activities

--5.00K

--14.00K

----

--0.00

-100.00%0.00

725.93%20.81K

3252.30%126.65K

--2.52K

--3.78K

--0.00

-100.00%0.00

--0.00

-97.05%1.32K

--0.00

--44.68K

----

Capital expenditures

--5.00K

--14.00K

----

--0.00

-100.00%0.00

725.93%20.81K

3252.30%126.65K

--2.52K

--3.78K

--0.00

-100.00%0.00

--0.00

-97.05%1.32K

--0.00

--44.68K

----

Net cash flow from disposal of fixed assets

--5.00K

--14.00K

----

--0.00

-100.00%0.00

725.93%20.81K

-100.00%0.00

--2.52K

--3.78K

--0.00

-100.00%0.00

--0.00

-97.05%1.32K

--0.00

--44.68K

----

Net cash flow from intangible asset transactions

----

--0.00

--126.65K

----

Net cash flow from investment products

-5300.00%-52.00K

----

100.20%1.00K

68.56%-254.00K

---512.00K

---808.00K

----

--0.00

100.00%0.00

--0.00

---277.00K

----

-100.00%0.00

--0.00

--103.95K

----

-100.00%0.00

-98.52%3.09K

--146.53K

--208.11K

Net cash flow from other investing activities

----

-99900.00%-1.00M

----

---1.00K

---2.67M

----

-100.00%0.00

100.00%0.00

--1.59K

---141.89K

Cash from non-current investing activities

Net cash flow from investing activities

94.29%-57.00K

94.49%-14.00K

-94.74%-999.00K

92.71%-254.00K

---513.00K

-16637.10%-3.48M

-725.93%-20.81K

-3252.30%-126.65K

---2.52K

---3.78K

--0.00

100.00%0.00

--0.00

99.59%-1.32K

--0.00

---321.67K

----

-100.00%0.00

--0.00

--103.95K

----

-100.00%0.00

-95.34%3.09K

--148.12K

--66.22K

Financing cash flow

Cash flow from continuous financing activities

5840.26%4.57M

-86.49%-69.00K

240.00%77.00K

---37.00K

---55.00K

100.00%0.00

-101.80%-274.69K

3478.04%59.21M

589957.61%15.26M

-76.73%1.65M

-99.91%2.59K

763.32%7.11M

295.33%2.85M

221.03%823.68K

-47.68%720.80K

-95.59%256.57K

-89.17%1.38M

358244.43%5.82M

71.03%12.72M

--1.62K

2987.35%7.44M

100.00%0.00

112.22%240.90K

---7.96K

--113.51K

Net cash flow from debt Issuance/repayment

12.20%-72.00K

-86.49%-69.00K

-49.09%-82.00K

---37.00K

---55.00K

--0.00

-100.00%0.00

31.98%-134.49K

--8.82K

61.61%-197.72K

-100.00%0.00

---515.05K

--547.08K

-100.00%0.00

-99.40%42.12K

-88.78%969.02K

--6.99M

110.99%8.64M

--0.00

--4.09M

----

Net cash flow from common stock issuance/repurchase

18945.83%4.57M

----

--24.00K

----

-100.00%0.00

2404632.71%60.56M

530820.32%13.73M

-100.03%-2.52K

-99.89%2.59K

805.27%7.46M

219.43%2.30M

284.09%823.68K

76.43%720.80K

--214.45K

-89.99%408.54K

----

22.07%4.08M

--1.62K

--3.34M

----

--113.51K

Proceeds from stock option exercised by employees

--75.00K

----

-100.00%0.00

--830.44K

--114.64K

----

Proceeds from issuance of warrants

----

--135.00K

----

--0.00

-100.00%0.00

-47.77%968.85K

--2.44M

26.63%1.86M

----

--1.46M

----

Net cash flow from other financing activities

----

100.00%0.00

73.54%-274.69K

---3.02M

---1.04M

100.00%0.00

--0.00

---1.30M

--0.00

----

--0.00

----

--0.00

---1.17M

----

--0.00

--240.90K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

5840.26%4.57M

-86.49%-69.00K

240.00%77.00K

---37.00K

---55.00K

100.00%0.00

-101.80%-274.69K

3478.04%59.21M

589957.61%15.26M

-76.73%1.65M

-99.91%2.59K

763.32%7.11M

295.33%2.85M

221.03%823.68K

-47.68%720.80K

-95.59%256.57K

-89.17%1.38M

358244.43%5.82M

71.03%12.72M

--1.62K

2987.35%7.44M

100.00%0.00

112.22%240.90K

---7.96K

--113.51K

Net cash flow

Beginning cash balance

-82.87%1.13M

-93.47%1.18M

-75.15%6.60M

-57.04%18.12M

--26.54M

-36.72%42.19M

35044.18%66.67M

1568.48%9.84M

-96.41%189.70K

600.78%590.03K

8239.29%5.29M

-96.90%84.20K

-98.97%63.39K

-73.44%2.71M

-48.29%6.13M

-0.40%10.22M

232.88%11.85M

85.52%10.26M

--3.56M

166860.13%5.53M

-100.00%0.00

-95.57%3.31K

-88.26%6.08K

--74.75K

--51.83K

Current period cash flow changes

147.91%2.59M

99.54%-53.00K

35.71%-5.41M

26.32%-11.53M

---8.42M

-17.31%-15.64M

-250.21%-13.34M

14663.76%53.56M

284.56%8.88M

-106.93%-367.74K

-19541.34%-4.81M

305.36%5.30M

100.73%24.74K

43.44%-2.58M

-280.23%-3.39M

-253.31%-4.57M

-112.47%-891.61K

242.85%2.98M

20.70%7.15M

-2331.45%-2.09M

191908.01%5.92M

239.71%93.46K

-115.07%-3.09K

---66.89K

--20.50K

Effect of exchange rate changes

101.61%3.00K

-334.18%-370.00K

-23.18%-186.00K

163.97%158.00K

---151.00K

---247.00K

----

Ending cash balance

214.79%3.72M

-82.87%1.13M

-93.47%1.18M

-75.15%6.60M

--18.12M

-50.27%26.54M

497.94%53.38M

32398.11%65.93M

1480.50%8.93M

-96.18%202.86K

547.99%564.84K

8092.24%5.31M

-96.67%87.17K

-98.88%64.86K

-76.26%2.62M

-55.78%5.80M

0.82%11.02M

271.83%13.12M

80.00%10.93M

3394.17%3.53M

199491.49%6.07M

1453.63%100.99K

-95.79%3.04K

--6.50K

--72.24K

Free cash flow

55.16%-1.93M

103.39%386.00K

44.09%-4.31M

4.37%-11.39M

---7.70M

8.79%-11.91M

-104.64%-13.06M

-179.53%-5.65M

-32.61%-6.38M

-11.96%-2.02M

-70.38%-4.81M

46.97%-1.81M

31.29%-2.82M

25.07%-3.41M

---4.11M

-60.04%-4.55M

----

-36.13%-2.84M

---5.57M

-2333.18%-2.09M

----

145.14%93.46K

-55.16%-247.07K

---207.05K

---159.24K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Tiziana Life Sciences Ltd Generate?



Tiziana Life Sciences Ltd generated -12.85M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Tiziana Life Sciences Ltd's Operating Cash Flow Change Year Over Year?



Tiziana Life Sciences Ltd's operating cash flow increased by -741.87% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Tiziana Life Sciences Ltd Spend on Capital Expenditures?



Tiziana Life Sciences Ltd spent 21.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Tiziana Life Sciences Ltd's Financing Cash Flow Changed?



Tiziana Life Sciences Ltd used 10.01M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TLSA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Tiziana Life Sciences Ltd’s free cash flow in the latest quarter?



Free cash flow was -12.87M reflecting a -732.88% change from the previous year.